BARINTHUS BIOTHERAPEUTICS PL (BRNS) Stock Analyst Earnings Estimates
NASDAQ:BRNS - Nasdaq - US91864C1071 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 44.703M 16,580.22% | 802K -98.21% | 14.969M 1,766.46% | -100.00% | |||
| EBITDA YoY % growth | 282K 100.63% | -78.485M -27,931.56% | -44.661M 43.10% | -88.06M -97.17% | -102.8M -16.74% | -99.45M 3.26% | |
| EBIT YoY % growth | -4.041M 91.06% | -83.914M -1,976.57% | -50.461M 39.87% | -63.164M -25.17% | -61.71M 2.30% | -89.76M -45.45% | |
| Operating Margin | -9.04% | -10,463.09% | -337.10% | N/A | N/A | N/A | |
| EPS YoY % growth | 0.13 106.33% | -1.92 -1,543.61% | -1.55 19.27% | -1.52 1.95% | -1.47 3.36% | -2.03 -38.19% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.34 21.72% | -0.35 -65.14% | -0.35 32.00% | -0.36 26.10% | -0.41 -21.21% | -0.46 -32.35% | -0.45 -29.41% | -0.49 -35.21% | -0.49 -20.00% | -0.53 -15.56% |
| Revenue Q2Q % growth | -100.00% | N/A | 221.34K | 885.36K | N/A | N/A | N/A | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -13.643M 25.39% | -14.153M -50.88% | -14.153M -26.58% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.49 -22.50% | -0.34 | -0.15 | -43.40% |
| Q4 2024 Q2Q % growth | -0.51 -13.33% | -0.42 | -0.09 | -20.97% |
| Q3 2024 Q2Q % growth | -0.21 43.24% | -0.45 | 0.24 | 53.56% |
| Q2 2024 Q2Q % growth | -0.43 30.65% | -0.42 | -0.01 | -1.99% |
| Q1 2024 Q2Q % growth | -0.40 16.67% | -0.55 | 0.15 | 27.91% |
| Q4 2023 Q2Q % growth | -0.45 20.63% | -0.51 | 0.06 | 11.66% |
| Q3 2023 Q2Q % growth | -0.37 -268.18% | -0.54 | 0.17 | 31.56% |
| Q2 2023 Q2Q % growth | -0.62 -251.22% | -0.56 | -0.06 | -11.12% |
| Q1 2023 Q2Q % growth | -0.48 -785.71% | -0.51 | 0.03 | 6.51% |
| Q4 2022 Q2Q % growth | -0.57 -49.21% | -0.43 | -0.13 | -30.80% |
| Q3 2022 Q2Q % growth | 0.22 269.23% | -0.34 | 0.56 | 165.36% |
| Q2 2022 Q2Q % growth | 0.41 164.06% | -0.33 | 0.74 | 224.35% |
| Q1 2022 Q2Q % growth | 0.07 107.37% | -0.32 | 0.39 | 122.14% |
| Q4 2021 Q2Q % growth | -0.38 | -0.31 | -0.07 | -21.15% |
| Q3 2021 Q2Q % growth | -0.13 | -0.46 | 0.33 | 71.83% |
| Q2 2021 Q2Q % growth | -0.64 | -0.75 | 0.11 | 15.21% |
| Q1 2021 Q2Q % growth | -0.95 | -2.15 | 1.20 | 55.86% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -100.00% | % | ||
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | -100.00% | 131.325K | -131.325K | -100.00% |
| Q3 2023 Q2Q % growth | -100.00% | 255K | -255K | -100.00% |
| Q2 2023 Q2Q % growth | 334K -98.04% | 612K | -278K | -45.42% |
| Q1 2023 Q2Q % growth | 468K -96.88% | 1.53M | -1.062M | -69.41% |
| Q4 2022 Q2Q % growth | 6.457M 2,309.33% | 3.378M | 3.079M | 91.15% |
| Q3 2022 Q2Q % growth | 6.165M 32,347.37% | 7.978M | -1.813M | -22.72% |
| Q2 2022 Q2Q % growth | 17.063M 48,651.43% | 3.637M | 13.426M | 369.15% |
| Q1 2022 Q2Q % growth | 15.018M 6,885.12% | 3.639M | 11.379M | 312.70% |
| Q4 2021 Q2Q % growth | 268K -24.14% | 414.803K | -146.803K | -35.39% |
| Q3 2021 Q2Q % growth | 19K -99.42% | 1.122M | -1.103M | -98.31% |
| Q2 2021 Q2Q % growth | 35K | 102K | -67K | -65.69% |
| Q1 2021 Q2Q % growth | 215K | 102K | 113K | 110.78% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -11.19% |
| Revenue | N/A | N/A | N/A | N/A |